echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > A new breakthrough in CAR-T cell therapy: successfully treating multiple patients with lupus erythematosus and achieving long-term drug-free remission

    A new breakthrough in CAR-T cell therapy: successfully treating multiple patients with lupus erythematosus and achieving long-term drug-free remission

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Written by


    EditorWang Duoyu


    TypesettingWater into writing


    Systemic lupus erythematosus (SLE) is a severe autoimmune disease with an incidence of 0.


    Professor Andreas Mackensen (left), Professor Georg Schett (right), and in the middle is Thu-Thao V, the world's first systemic lupus erythematosus patient treated with CAR-T cells.


    On September 15, 2022, the team of Professor Georg Schett and others published a research paper
    entitled Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus in Nature Medicine.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.